UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reduced injection risk behavior with co-located hepatitis C treatment at a syringe service program: The accessible care model

PloS one, 2024-08, Vol.19 (8), p.e0308102

2024

Volltextzugriff (PDF)

Assessing routes of hepatitis C transmission in HIV-infected men who have sex with men using single genome sequencing

PloS one, 2020-07, Vol.15 (7), p.e0235237

2020

Volltextzugriff (PDF)

"Treated like a Human Being": perspectives of people who inject drugs attending low-threshold HCV treatment at a syringe service program in New York City

Harm reduction journal, 2023-07, Vol.20 (1), p.95-95, Article 95

2023

Volltextzugriff (PDF)

Rapid Progression to Decompensated Cirrhosis, Liver Transplant, and Death in HIV-infected Men After Primary Hepatitis C Virus Infection

Clinical infectious diseases, 2013-04, Vol.56 (7), p.1038-1043

2013

Volltextzugriff (PDF)

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

The New England journal of medicine, 2020-11, Vol.383 (19), p.1827-1837

2020

Volltextzugriff (PDF)

Accessible Hepatitis C Care for People Who Inject Drugs: A Randomized Clinical Trial

JAMA internal medicine, 2022-05, Vol.182 (5), p.494

2022

Volltextzugriff (PDF)

Cost of providing co-located hepatitis C treatment at a syringe service program exceeds potential reimbursement: Results from a clinical trial

Drug and alcohol dependence reports, 2022-12, Vol.5, p.100109, Article 100109

2022

Volltextzugriff (PDF)

Hepatitis C Management Simplification From Test to Cure: A Framework for Primary Care Providers

Clinical therapeutics, 2018-08, Vol.40 (8), p.1234-1245

2018

Volltextzugriff (PDF)

Histological Findings and Clinical Characteristics Associated with Hepatic Steatosis in Patients Coinfected with HIV and Hepatitis C Virus

The Journal of infectious diseases, 2005-12, Vol.192 (11), p.1943-1949

2005

Volltextzugriff (PDF)

Hepatitis C Treatment by Nonspecialist Providers in the Direct-acting Antiviral Era

Medical care, 2021-09, Vol.59 (9), p.795-800

2021

Volltextzugriff (PDF)

Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency Virus

Clinical infectious diseases, 2023-08, Vol.77 (3), p.414-418

2023

Volltextzugriff (PDF)

Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1–Infected Individuals: SWIFT-C

Clinical infectious diseases, 2017-04, Vol.64 (8), p.1035-1042

2017

Volltextzugriff (PDF)

Remdesivir Treatment for Severe COVID-19 in Third-Trimester Pregnancy: Case Report and Management Discussion

Open forum infectious diseases, 2020-09, Vol.7 (9), p.ofaa345

2020

Volltextzugriff (PDF)

Rapid Treatment Initiation for Hepatitis C Virus Infection: Potential Benefits, Current Limitations, and Real-World Examples

Gastroenterology & hepatology, 2022-11, Vol.18 (11), p.628-638

2022

Volltextzugriff (PDF)

Rapid Treatment Initiation for Hepatitis C in Young People Who Inject Drugs: The Seek, Test, and Rapid Treatment Randomized Trial

Open forum infectious diseases, 2022-07, Vol.9 (7), p.ofac225-ofac225

2022

Volltextzugriff (PDF)

Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals

Clinical infectious diseases, 2019-07, Vol.69 (3), p.514-522

2019

Volltextzugriff (PDF)

Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate

Journal of antimicrobial chemotherapy, 2018-08, Vol.73 (8), p.2112-2119

2018

Volltextzugriff (PDF)

Management of hepatitis B and C infections in rheumatologic disease

Best practice & research. Clinical rheumatology, 2018-12, Vol.32 (6), p.848-868

2018

Volltextzugriff (PDF)

Strategies for Improving Hepatitis C Treatment Access in the United States: State Officials Address High Drug Prices, Stigma, and Building Treatment Capacity

Journal of public health management and practice, 2019-05, Vol.25 (3), p.245-252

2019

Volltextzugriff (PDF)

Diagnosis and Genotyping of Coxiella burnetii Endocarditis in a Patient with Prosthetic Pulmonary Valve Replacement Using Next-Generation Sequencing of Plasma Microbial Cell-Free DNA

Open forum infectious diseases, 2019-06, Vol.6 (6), p.ofz242-ofz242

2019

Volltextzugriff (PDF)

The first wave: HCV NS3 protease inhibitors telaprevir and boceprevir

Antiviral therapy, 2012, Vol.17 (6), p.1119-1131

2012

Volltextzugriff (PDF)

COVID-19

Annals of internal medicine, 2023-10, Vol.176 (10), p.ITC145-ITC160

2023

Volltextzugriff (PDF)

Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy

Journal of acquired immune deficiency syndromes (1999), 2009-12, Vol.52 (5), p.595-599

2009

Volltextzugriff (PDF)

1 – 25 von 240

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(212)
Mit Volltextzugriff
(186)

Publikationsform

Sprache

Englisch
(240)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Reduced injection risk behavior with co-located hepatitis C treatment at a syringe service program: The accessible care model

Assessing routes of hepatitis C transmission in HIV-infected men who have sex with men using single genome sequencing

"Treated like a Human Being": perspectives of people who inject drugs attending low-threshold HCV treatment at a syringe service program in New York City

Rapid Progression to Decompensated Cirrhosis, Liver Transplant, and Death in HIV-infected Men After Primary Hepatitis C Virus Infection

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

Accessible Hepatitis C Care for People Who Inject Drugs: A Randomized Clinical Trial

Cost of providing co-located hepatitis C treatment at a syringe service program exceeds potential reimbursement: Results from a clinical trial

Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

Hepatitis C Management Simplification From Test to Cure: A Framework for Primary Care Providers

Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019

Histological Findings and Clinical Characteristics Associated with Hepatic Steatosis in Patients Coinfected with HIV and Hepatitis C Virus

Hepatitis C Treatment by Nonspecialist Providers in the Direct-acting Antiviral Era

Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency Virus

Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1–Infected Individuals: SWIFT-C

Remdesivir Treatment for Severe COVID-19 in Third-Trimester Pregnancy: Case Report and Management Discussion

Rapid Treatment Initiation for Hepatitis C Virus Infection: Potential Benefits, Current Limitations, and Real-World Examples

Rapid Treatment Initiation for Hepatitis C in Young People Who Inject Drugs: The Seek, Test, and Rapid Treatment Randomized Trial

Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals

Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate

Management of hepatitis B and C infections in rheumatologic disease

Strategies for Improving Hepatitis C Treatment Access in the United States: State Officials Address High Drug Prices, Stigma, and Building Treatment Capacity

Diagnosis and Genotyping of Coxiella burnetii Endocarditis in a Patient with Prosthetic Pulmonary Valve Replacement Using Next-Generation Sequencing of Plasma Microbial Cell-Free DNA

The first wave: HCV NS3 protease inhibitors telaprevir and boceprevir

COVID-19

Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy

Suchergebnisse filtern